By continuing your visit to this site, you accept the use of cookies. These ensure the smooth running of our services. Learn more.

Jul 11, 2007

Myomo e100 NeuroRobotic System

Via Medgadget 

US company Myomo has announced that the e100 NeuroRobotic System, a technology designed to help in the rehabilitation process of patients by "engaging and reinforcing both neurological and motor pathways,"  has received FDA clearance to market.

How it Works

  • Patient's brain is the controller: When a patient attempts movement during therapy, their muscles contract and electrical muscle activity signals fire

  • Non-invasive sensing: An EMG sensor sits on the skin's surface to detect and continuously monitor a person's residual electrical muscle activity

  • Proprietary system software: Advanced signal processing software filters and processes the user's EMG signal, and then forwards the data to a robotic device

  • Proportional assistance: Portable, wearable robotics use the person's EMG signal to assist with desired movement; power assistance is customized to patient ability with Myomo's real-time adjustable control unit.



Product page: Myomo e100 NeuroRobotic System ...


The comments are closed.